Labeling Format Differentiation Minimized By Rule Implementation Timeline
Executive Summary
FDA's implementation timeline for the physician labeling rule may mean that advent of the new labeling format will have limited impact on currently available competing products
You may also be interested in...
Labeling Rule Requires Sponsors To Start Safety Discussions With FDA Earlier
Sponsors will need to discuss safety updates to product labeling in the new format ahead of a submission to the agency in order to facilitate the prior approval necessary under the physician labeling rule
Labeling Rule Requires Sponsors To Start Safety Discussions With FDA Earlier
Sponsors will need to discuss safety updates to product labeling in the new format ahead of a submission to the agency in order to facilitate the prior approval necessary under the physician labeling rule
Merck Re-Enters Oncology With Zolinza Approval For Rare Skin Cancer
Merck's oncologic Zolinza will be available mid-October at a cost of $60 per capsule, the company said following vorinostat's Oct. 6 approval for a rare skin cancer.